Noam Diamant, based in Israel, is currently a Co-Founder and CEO at NOGA Therapeutics, bringing experience from previous roles at Emendo Biotherapeutics, Ingenium IP, The National Institute for Biotechnology in the Negev and Eventus Diagnostics, Inc.. Noam Diamant holds a 2014 - 2015 Intellectual Property Law @ WIPO Academy. With a robust skill set that includes High Throughput Screening, qPCR, Cell Biology, ELISA, Transfection and more, Noam Diamant contributes valuable insights to the industry. Noam Diamant has 3 emails on RocketReach.